[Treatment of an asthmatic patient on dialysis and awaiting transplantation with anti-IgE].
BACKGROUND
Omalizumab, a monoclonal antibody to IgE, is a possible treatment for severe, uncontrolled allergic asthma.


METHODS
A severe asthmatic patient with renal insufficiency and on dialysis was awaiting transplantation. The asthma was uncontrolled with poor respiratory function. He received anti IgE treatment with omazilumab with immediate clinical improvement and his renal transplant was performed satisfactorily.


CONCLUSIONS
Anti-IgE treatment can improve severe, uncontrolled allergic asthmatic patients allowing, in this case, transplantation without further respiratory problems.
Lafourcade
M-P
MP
Service de Pneumologie, Centre hospitalier d'Angoulême, Saint Michel, France. mpierre.lafourcade@wanadoo.fr
Martin
M
M
Yver
L
L
D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D000069444:Omalizumab; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications / Q000601:surgery / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C026408:anti-IgE antibodies; D000069444:Omalizumab